Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose control
Authors:
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 142, 188-194
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive SummaryEndocrine Practice, 2017
- Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi ArabiaPrimary Care Diabetes, 2016
- Quality measure attainment with dapagliflozin plus metformin extended-release as initial combination therapy in patients with type 2 diabetes: a post hoc pooled analysis of two clinical studiesRisk Management and Healthcare Policy, 2016
- Efficacy and safety of triple therapy with dapagliflozin add‐on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetesDiabetes, Obesity and Metabolism, 2016
- Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment periodJournal of Diabetes Investigation, 2016
- Insulin Therapy for Type 2 Diabetes MellitusJAMA, 2014
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24‐week, double‐blind, placebo‐controlled trialDiabetes, Obesity and Metabolism, 2011
- Prevalence, predisposition and prevention of type II diabetesNutrition & Metabolism, 2005
- Identifying the links between obesity, insulin resistance and β‐cell function: potential role of adipocyte‐derived cytokines in the pathogenesis of type 2 diabetesEuropean Journal of Clinical Investigation, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001